Moreover, the standard treatment of GBM with radiation and TMZ can induce expression of COX-2 and leading to radiochemoresistance, as overproduction of COX-2/PGE2 in tumor cells is correlated with shorter survival of patients [18,19]. The gene discussed is PTGS2; the disease is neoplasm.